ArticleOncotarget2019

Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift.

Monique M P Speirs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.